Literature DB >> 26057537

Mimicking and Understanding the Agglutination Effect of the Antimicrobial Peptide Thanatin Using Model Phospholipid Vesicles.

Émile Robert1, Thierry Lefèvre1, Matthieu Fillion1, Benjamin Martial1, Justine Dionne1, Michèle Auger1.   

Abstract

Thanatin is a cationic 21-residue antimicrobial and antifongical peptide found in the spined soldier bug Podisus maculiventris. It is believed that it does not permeabilize membranes but rather induces the agglutination of bacteria and inhibits cellular respiration. To clarify its mode of action, lipid vesicle organization and aggregation propensity as well as peptide secondary structure have been studied using different membrane models. Dynamic light scattering and turbidimetry results show that specific mixtures of negatively charged and zwitterionic phospholipid vesicles are able to mimic the agglutination effect of thanatin observed on Gram-negative and Gram-positive bacterial cells, while monoconstituent ("conventional") models cannot reproduce this phenomenon. The model of eukaryotic cell reveals no particular interaction with thanatin, which is consistent with the literature. Infrared spectroscopy shows that under the conditions under which vesicle agglutination occurs, thanatin exhibits a particular spectral pattern in the amide I' region and in the region associated with Arg side chains. The data suggest that thanatin mainly retains its hairpin structure, Arg residues being involved in strong interactions with anionic groups of phospholipids. In the absence of vesicle agglutination, the peptide conformation and Arg side-chain environment are similar to those observed in solution. The data show that a negatively charged membrane is required for thanatin to be active, but this condition is insufficient. The activity of thanatin seems to be modulated by the charge surface density of membranes and thanatin concentration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26057537     DOI: 10.1021/acs.biochem.5b00442

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Rapid Formation of Peptide/Lipid Coaggregates by the Amyloidogenic Seminal Peptide PAP248-286.

Authors:  Eleanor W Vane; Shushan He; Lutz Maibaum; Abhinav Nath
Journal:  Biophys J       Date:  2020-08-06       Impact factor: 4.033

2.  Antibacterial effects assessment on some livestock pathogens, thermal stability and proposing a probable reason for different levels of activity of thanatin.

Authors:  Ali Javadmanesh; Elyas Mohammadi; Zahra Mousavi; Marjan Azghandi; Abass Tanhaiean
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

3.  Structure and Interactions of A Host Defense Antimicrobial Peptide Thanatin in Lipopolysaccharide Micelles Reveal Mechanism of Bacterial Cell Agglutination.

Authors:  Sheetal Sinha; Liangzhen Zheng; Yuguang Mu; Wun Jern Ng; Surajit Bhattacharjya
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

4.  Expression of Thanatin in HEK293 Cells and Investigation of its Antibacterial Effects on Some Human Pathogens.

Authors:  Abbas Tanhaeian; Marjan Azghandi; Zahra Mousavi; Ali Javadmanesh
Journal:  Protein Pept Lett       Date:  2020       Impact factor: 1.890

Review 5.  Thanatin: An Emerging Host Defense Antimicrobial Peptide with Multiple Modes of Action.

Authors:  Rachita Dash; Surajit Bhattacharjya
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

6.  Contribution of Amphipathicity and Hydrophobicity to the Antimicrobial Activity and Cytotoxicity of β-Hairpin Peptides.

Authors:  Ingrid A Edwards; Alysha G Elliott; Angela M Kavanagh; Johannes Zuegg; Mark A T Blaskovich; Matthew A Cooper
Journal:  ACS Infect Dis       Date:  2016-04-29       Impact factor: 5.084

7.  Lectin-mediated protocell crosslinking to mimic cell-cell junctions and adhesion.

Authors:  Sarah Villringer; Josef Madl; Taras Sych; Christina Manner; Anne Imberty; Winfried Römer
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.